Jonas Marschall
Overview
Explore the profile of Jonas Marschall including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
156
Citations
2092
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Passaretti C, Bischoff W, Chan J, Diekema D, Doron S, Estelle C, et al.
Infect Control Hosp Epidemiol
. 2024 Dec;
:1-2.
PMID: 39628050
No abstract available.
2.
Stevens M, Emetuche N, Passaretti C, Snyder G, Snyders R, Edmond M, et al.
Infect Control Hosp Epidemiol
. 2024 Oct;
1-3.
PMID: 39463271
A 54-question survey about System Healthcare Infection Prevention Programs (SHIPPs) was sent out to SHEA Research Network participants in August 2023. Thirty-eight United States-based institutions responded (38/93, 41%), of which...
3.
Thurnheer M, Schurmann A, Huber M, Marschall J, Wuethrich P, Burkhard F
JAMA Netw Open
. 2024 Oct;
7(10):e2439382.
PMID: 39422911
Importance: Perioperative antibiotic prophylaxis (PAP) reduces the incidence of surgical site infections (SSIs). Guidelines recommend 24 hours or less of PAP for cystectomy with urinary diversion; however, evidence specifying optimal...
4.
Birrer M, Draps K, Hobi F, Laguardia M, Hofmann E, Luginbuhl M, et al.
Infect Prev Pract
. 2024 Aug;
6(3):100386.
PMID: 39205825
Single room isolation for respiratory viral infections (RVI), like influenza, puts hospitals under pressure. During the influenza season 2019/20, we implemented (DroPS) for RVI in two acute care hospitals and...
5.
Sax H, Marschall J
Antimicrob Resist Infect Control
. 2024 Aug;
13(1):88.
PMID: 39135082
Background: Healthcare delivery is undergoing radical changes that influence effective infection prevention and control (IPC). Futures research (short: Futures), the science of deliberating on multiple potential future states, is increasingly...
6.
Marra A, Lopes G, Pardo I, Hsieh M, Kobayashi T, Marra P, et al.
Diagn Microbiol Infect Dis
. 2024 Jul;
110(2):116465.
PMID: 39059148
Metagenomic Next-Generation Sequencing (mNGS) holds promise in diagnosing fever of unknown origin (FUO) by detecting diverse pathogens. We systematically reviewed the literature to evaluate mNGS's accuracy, clinical efficacy, and limitations...
7.
Liang S, Osdieck S, Daugherty A, Davis A, Babcock H, Marschall J
J Occup Environ Med
. 2024 Jun;
66(9):e440-e441.
PMID: 38900930
No abstract available.
8.
Widmer A, Atkinson A, Kuster S, Wolfensberger A, Klimke S, Sommerstein R, et al.
JAMA
. 2024 Jun;
332(7):541-549.
PMID: 38884982
Importance: Preoperative skin antisepsis is an established procedure to prevent surgical site infections (SSIs). The choice of antiseptic agent, povidone iodine or chlorhexidine gluconate, remains debated. Objective: To determine whether...
9.
Cortes-Penfield N, Beekmann S, Polgreen P, Ryan K, Marschall J, Sekar P
Open Forum Infect Dis
. 2024 Jun;
11(6):ofae280.
PMID: 38868304
Background: Osteoarticular infections (OAIs) are commonly treated with prolonged intravenous (IV) antimicrobials. The Oral versus Intravenous Antibiotics for Bone and Joint Infection (OVIVA) trial demonstrated that oral (PO) antibiotics are...
10.
Advani S, Cawcutt K, Klompas M, Marschall J, Meddings J, Patel P
Infect Control Hosp Epidemiol
. 2024 Jan;
45(6):693-697.
PMID: 38221847
In recent years, it has become increasingly evident that surveillance metrics for invasive device-associated infections (ie, central-line-associated bloodstream infections, ventilator-associated pneumonias, and catheter-associated urinary tract infections) do not capture all...